The Fiji Medical Association has thrown its weight behind the Government’s plan to introduce drug testing for public officials — but urged that any programme must be built on scientific evidence, clear policy and human-rights protections to avoid doing more harm than good.
FMA president Dr Ronal Kumar said the association recognised the dangers posed by illicit drugs but warned that testing alone “is not a solution.” “Drug testing is a medical, ethical and public‑health issue and not merely a disciplinary one,” he said, stressing that the programme must be governed by “clear policy, scientific evidence and human‑rights principles.”
Dr Kumar cautioned that poorly designed testing schemes have international precedents for producing misleading outcomes. “International experience shows that drug testing, when poorly designed, can lead to misinterpretation of results, unfair consequences for workers … and stigma that discourages people from seeking help,” he said. The FMA’s statement highlighted the risks of converting a health problem into a punitive exercise that could drive dependent workers away from treatment.
The association also emphasised important scientific caveats about drug testing. “A positive result does not necessarily mean a person is intoxicated, unsafe to work, or using drugs at the time of testing,” Dr Kumar said, pointing to the difference between detecting drug metabolites and demonstrating current impairment. The FMA urged that any policy distinguish between past use, current intoxication and dependence, and that confirmatory testing and robust chain‑of‑custody procedures be included to reduce false positives and misinterpretation.
Beyond test accuracy, the FMA pressed for safeguards around confidentiality, due process and access to treatment. The association said drug dependence should be managed primarily as a health issue rather than treated automatically as cause for disciplinary action. It called for integrated pathways that link a positive test result to medical assessment, counselling and evidence‑based treatment options, alongside clear appeal mechanisms for workers who contest results.
The association’s position comes as the Government moves to formalise screening for public servants and officials — a measure proponents say will protect public safety and integrity. The FMA’s intervention frames that step as an opportunity to design a measured policy that balances workplace safety with individual rights and public‑health best practice. Dr Kumar warned that without those safeguards, testing risks producing “unfair consequences” and entrenching stigma rather than promoting recovery.
By setting out these conditions, the Fiji Medical Association has signalled conditional support for the initiative while attempting to shape its implementation. Its guidance underscores the need for transparent rules, scientific rigour and health‑centred responses if drug testing is to be effective and just.